Strategic Market Access Solutions
Evidence Led
Commercially Focused

Delivering the complete market access strategy from development to launch success

Contact

WHAT WE DO

Delivering JCA programme end to end

Strategic direction, PICO strategy, evidence and analytical planning, dossier authoring, and the response phase after submission.

Authored and submitted a JCA dossier in oncology immunotherapy under a live statutory deadline.

Wright Pharma Partnering Ltd designs market access strategy that is clear, evidence-based and commercially focused. We support pharmaceutical clients with structured services across global market access strategy, evidence generation, pricing narratives, value communication, and local implementation.

Working as your team member, we bring clarity and focus to every step. The goal: to deliver strategies that stand up to payer scrutiny.
Twenty years across global, regional and national HTA, brought directly to your team.

✓ Two decades of experience across the pharma industry

✓ Four years delivering client-focused results

✓ Senior consultant providing tailor made solutions

✓ Delivering a suite of Market Access solutions through preferred partnership models

TESTIMONIALS

  • “Elaine Wright is one of the strongest market access experts in our business. In the nearly 10 years I have worked with Elaine she has constantly provided strong technical expertise, clear, coherent strategy, and flawless execution in support of our oncology portfolio. Her tremendous skills resulted in her being a much sought expert beyond market access, HEOR and pricing, and as a result assumed roles of increasing accountability in our global commercial business and country specific strategic leadership.”

    Brian O'Shea
    Genentech

  • “Elaine has extensive expertise in Access and Value demonstration, which is consistently shown in the high quality of her work. She is detail-focused, while maintaining a strong strategic perspective. Elaine is not only reliable but also a pleasure to collaborate with. Elaine has led several projects with us, consistently demonstrating exceptional project management skills that guarantee high-quality deliverables on time. She has deep knowledge and expertise on access, value demonstration and evidence generation topics. She quickly understands your needs and is able to transform ideas into actionable, tangible outcomes. Elaine offers invaluable insights and guidance throughout the process. In summary, working with Elaine is synonymous with success and a hallmark of quality.”

    Natalia Arrabal,
    Italfarmaco

  • “Elaine brought  out-of-the-box innovative solutions and an energy to the team. A forward momentum and focus towards our common goal. Her pro-active problem-solving and collaborative approach made her a highly valuable team member. I would highly recommend Elaine as a peer resource, and I hope to work with her again in the future.”

    Maiko Liebermann,  F. Hoffmann-La Roche

  • “Thank you so much Elaine for giving this guest lecture. You explained really well the importance and the intricacies of Market Access. It was of huge benefit to the students to learn from your rich experience.”

    Ronan Mahon
    National University of Ireland, Galway. Lecturer in Health Economics

01. Strategy

Global Market Access Strategy That’s Integrated

We support Market Access leaders in designing cohesive, forward-looking strategy across evidence, pricing and communication. Whether you’re developing a launch plan, testing strategic scenarios or aligning cross-functional teams, we bring clarity and structure to complex environments.

✓Market Access Strategy Development

✓JCA (joint clinical assessment) Strategy Development and Implementation

✓Specific Strategy Mitigation from MFN (most favoured nation) and other pricing risks

✓Scenario Planning and Design Thinking Workshops

✓Global Value Dossier and Value Proposition Development

✓Pricing and Access Narrative Development

✓JCA Simulation and Preparation

02. Evidence by Design

HTA Evidence Planning and Access and Pricing Narrative Development

We help you build a value story that is grounded in evidence, credible across stakeholders and adaptable to country needs. From early evidence gap analysis to pricing narrative creation, we ensure your messages hold up to scrutiny and your teams are aligned on what matters.

✓HTA and Real World Evidence Generation; Planning and Delivery

✓JCA Evidence Planning and Generation

03. Implementation

Global Coordination for Local Reimbursement and Capability Building

We work with global teams to support affiliates with consistent tools, messages and training. Whether preparing a submission, launching a narrative or building internal capability, we act as your team member to ensure local teams are ready, and confident.

✓ HTA and HEOR Training and Capability Building

✓ Coordinated Global to Local Reimbursement Submission

✓ Conducting Local Reimbursement Submissions in the UK and Ireland

✓ Global to Local Message Matrix and Q&A Resource Creation, Dissemination and Training

✓ Pricing Risk Scanning and Sentiment Monitoring

✓ Framing the Societal Impact and Publications

✓ Excellence in Execution: AI Market Access and HTA Readiness and Training

CASE STUDIES

  • Designed a multi-scenario playbook for a rare disease product, addressing pricing, trial outcomes and regulatory variations. Enabled earlier alignment and readiness across cross-functional teams, helping the client prepare for potential JCA and HTA outcomes with confidence and speed.

  • Supported a mid-size biopharma with a sensitive EU launch by developing a unified pricing and access narrative. Through structured interviews and workshops, we translated complex data into clear messaging, ensuring consistency across the organisation and strengthening internal communication.

  • Item description

  • Created accessible, visual training modules to improve understanding of network meta-analysis among medical and commercial teams. Helped the client build internal capability to confidently communicate HTA-published evidence and engage more effectively with payers.

  • Guest lecture introducing Global Market Access Strategy to students at NUI Galway MSc in Health Economics.

  • Developed a real-time sentiment monitoring dashboard for a rare disease launch. Anticipated pricing-related reputational risks and informed senior management with actionable insights, ensuring consistent messaging and proactive risk mitigation across European markets.

  • Item description
A smiling young woman with shoulder-length brown hair, earrings, a white top, and a gold pendant necklace, sitting indoors with a colorful floral painting and green wall in the background.

WRIGHT Pharma Partnering Ltd delivers clear, evidence-based market access strategy for pharmaceutical companies.

Founded in 2022 by Elaine Wright, the company offers direct access to senior expertise without the overhead of a large consultancy. Clients work one-to-one with the principal consultant for strategic depth, continuity and practical support.

The focus: high-stakes access challenges, modular tools for planning, and readiness for AI-enabled decision-making always delivered with clarity, structure and outcomes in mind.

Brian O'Shea, Genentech

“Elaine Wright is one of the strongest market access experts in our business…”

Natalia Arrabal, Italfarmaco 

​“…working with Elaine is synonymous with success and a hallmark of quality.”